Okubo Shinji, Tanabe Yujirou, Takeda Kenji, Kitayama Michihiko, Kanemitsu Seiyu, Kukreja Rakesh C, Takekoshi Noboru
Dept. of Cardiology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0293, Japan.
Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1786-91. doi: 10.1152/ajpheart.01143.2003. Epub 2004 Jul 1.
We examined whether ischemic preconditioning (IPC) attenuates ischemia-reperfusion injury, in part, by decreasing apoptosis and whether the delta-opioid receptor (DOR) plays a pivotal role in the regulation of apoptosis. Rabbits were subjected to 30-min coronary artery occlusion (CAO) and 180 min of reperfusion. IPC was elicited with four cycles of 5-min ischemia and 10-min reperfusion before CAO. Morphine (0.3 mg/kg iv) was given 15 min before CAO. Naloxone (Nal; 10 mg/kg iv) and naltrindole (Nti; 10 mg/kg iv), the respective nonselective and selective DOR antagonists were given 10 min before either morphine or IPC. Infarct size (%risk area) was reduced from 46 +/- 3.8 in control to 11.6 +/- 1.0 in IPC and 19.5 +/- 3.8 in the morphine group (means +/- SE; P < 0.001 vs. control). Nal blocked the protective effects of IPC and morphine, as shown by the increase in infarct size to 38.6 +/- 7.2 and 44.5 +/- 1.8, respectively. Similarly, Nti blocked IPC and morphine-induced protection. The percentage of apoptotic cells (revealed by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay) decreased in IPC (3.6 +/- 1.9) and morphine groups (5.2 +/- 1.2) compared with control group (12.4 +/- 1.6; P < 0.001). Nti pretreatment increased apoptotic cells 11.2 +/- 2.2% in IPC and 12.1 +/- 0.8% in morphine groups. Nal failed to block inhibition of apoptosis in the IPC group (% of cells: 5.7 +/- 1.3 vs. 3.6 +/- 1.9 in IPC alone; P > 0.05). These results were also confirmed by nucleosomal DNA laddering pattern. We conclude that IPC reduces lethal injury, in part, by decreasing apoptosis after ischemia-reperfusion and activation of the DOR may play a crucial role in IPC or morphine-induced myocardial protection.
我们研究了缺血预处理(IPC)是否部分通过减少细胞凋亡来减轻缺血再灌注损伤,以及δ-阿片受体(DOR)在细胞凋亡调节中是否起关键作用。对兔子进行30分钟冠状动脉闭塞(CAO)和180分钟再灌注。在CAO之前,通过四个5分钟缺血和10分钟再灌注周期引发IPC。在CAO前15分钟静脉注射吗啡(0.3mg/kg)。在给予吗啡或IPC前10分钟,分别给予非选择性和选择性DOR拮抗剂纳洛酮(Nal;10mg/kg静脉注射)和纳曲吲哚(Nti;10mg/kg静脉注射)。梗死面积(%危险区域)从对照组的46±3.8降至IPC组的11.6±1.0和吗啡组的19.5±3.8(平均值±标准误;与对照组相比,P<0.001)。Nal阻断了IPC和吗啡的保护作用,梗死面积分别增加到38.6±7.2和44.5±1.8。同样,Nti阻断了IPC和吗啡诱导的保护作用。与对照组(12.4±1.6;P<0.001)相比,IPC组(3.6±1.9)和吗啡组(5.2±1.2)中凋亡细胞百分比(通过末端脱氧核苷酸转移酶介导的dUTP缺口末端标记法显示)降低。Nti预处理使IPC组凋亡细胞增加11.2±2.2%,吗啡组增加12.1±0.8%。Nal未能阻断IPC组中细胞凋亡的抑制作用(细胞百分比:单独IPC组为3.6±1.9,Nal处理后为5.7±1.3;P>0.05)。核小体DNA梯状图谱也证实了这些结果。我们得出结论,IPC部分通过减少缺血再灌注后的细胞凋亡来减轻致命性损伤,DOR的激活可能在IPC或吗啡诱导的心肌保护中起关键作用。